Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 3284 entries
View as:

Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD

Phase: N/A Priority: Normal
NCT ID: NCT02670642 Org: User:
Start: 08/31/01 End: 11/30/02 Due: 11/30/03

A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01297062 Org: User:
Start: 02/28/11 End: 05/31/11 Due: 05/31/12

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02574637 Org: User:
Start: 01/05/16 End: 01/29/18 Due: 01/29/19

Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets

Phase: N/A Priority: Normal
NCT ID: NCT01744288 Org: User:
Start: 12/31/12 End: 04/30/14 Due: 04/30/15

Osimertinib Study in Indian Patients

Phase: N/A Priority: Normal
NCT ID: NCT03853551 Org: User:
Start: 04/18/19 End: 04/15/20 Due: 04/15/21

Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study

Phase: N/A Priority: Normal
NCT ID: NCT00318539 Org: User:
Start: 12/31/03 End: 08/31/06 Due: 08/31/07

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

Phase: N/A Priority: Normal
NCT ID: NCT05925803 Org: User:
Start: 11/08/23 End: 12/31/27 Due: 12/31/28

Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02993614 Org: User:
Start: 11/30/17 End: 12/17/20 Due: 12/17/21

AZD5672 Bioavailability Study in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00871767 Org: User:
Start: 03/31/09 End: 05/31/09 Due: 05/31/10

Arimidex in McCune Albright Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00055302 Org: User:
Start: 08/31/02 End: 08/31/15 Due: 08/31/16

PPI Test in GP Patients

Phase: N/A Priority: Normal
NCT ID: NCT00318084 Org: User:
Start: 01/31/03 End: - Due: -

Change in Symptom and Quality of Life in COPD by Budesonide/Glycopyrronium/Formoterol Fumarate Pressurized Metered Dose Inhaler (BGF pMDI)

Phase: N/A Priority: Normal
NCT ID: NCT05219630 Org: User:
Start: 05/16/22 End: 05/30/23 Due: 05/30/24

A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03800134 Org: User:
Start: 12/06/18 End: 09/11/28 Due: 09/11/29

Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01003158 Org: User:
Start: 10/31/09 End: 04/30/12 Due: 04/30/13

A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06304961 Org: User:
Start: 04/08/24 End: 09/09/24 Due: 09/09/25

China Survey of Stress Ulcer Bleeding in Critically Ill Neurosurgical Patients

Phase: N/A Priority: Normal
NCT ID: NCT02316990 Org: User:
Start: 01/31/15 End: 07/31/15 Due: 07/31/16

A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)

Phase: N/A Priority: Normal
NCT ID: NCT04612725 Org: User:
Start: 10/27/20 End: 03/28/23 Due: 03/28/24

A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as 1L Treatment for the Chinese Patients With Unresectable Biliary Tract Cancers (BTC)

Phase: N/A Priority: Normal
NCT ID: NCT05924880 Org: User:
Start: 07/21/23 End: 02/07/25 Due: 02/07/26

Real-life Treatment Outcomes of Ravulizumab in PNH

Phase: N/A Priority: Normal
NCT ID: NCT06633536 Org: User:
Start: 02/06/25 End: 08/01/28 Due: 08/01/29

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04087174 Org: User:
Start: 08/05/19 End: 06/22/21 Due: 06/22/22

Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

Phase: N/A Priority: Normal
NCT ID: NCT01147588 Org: User:
Start: 05/31/10 End: 05/31/11 Due: 05/31/12

Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)

Phase: N/A Priority: Normal
NCT ID: NCT01974752 Org: User:
Start: 04/30/14 End: 10/31/16 Due: 10/31/17

Pattern of Statins Use in Catalonia

Phase: N/A Priority: Normal
NCT ID: NCT01477944 Org: User:
Start: 02/29/12 End: 02/29/12 Due: 02/28/13

Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02968914 Org: User:
Start: 01/04/17 End: 07/13/17 Due: 07/13/18

Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)

Phase: N/A Priority: Normal
NCT ID: NCT00897390 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10